U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ATryn
  1. Approved Blood Products

STN: BL 125284
Proper Name: Antithrombin (Recombinant)
Tradename: ATryn
Manufacturer: GTC Biotherapeutics, Inc., License # 1794
Indication:

  • Antithrombin (Recombinant) is indicated for the prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.

Product Information

Supporting Documents

Back to Top